From: Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS)
Site of recurrent disease
Number of patients
(total = 137)
Percentage of patients
Locoregional disease
88
64.2%
Distant soft tissues
16
11.7%
Other distant metastasis
33
24.1%